Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting BCL11A distal regulatory elements with a CAS9-CAS9 fusion for fetal hemoglobin reinduction

Targeting BCL11A distal regulatory elements with a CAS9-CAS9 fusion for fetal hemoglobin reinduction

US Patent 12098363 · Granted Sep 24, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Functional genomics using CRISPR-CAS systems for saturating mutagenesis of non-c2025
Treatment method on a surface of a plastic flowerpot2025
Flight anti-collision method and apparatus based on electromagnetic field detect2025
Microhomology mediated repair of microduplication gene mutations2025
Glycosylation method involving trivalent iodine reagent2025
Light emitting diode arrangements for gemstone evaluation2024
Compositions and methods for differential Cas9 gene labeling and/or editing2024
BCL11A guide delivery2023
Functional genomics using CRISPR-Cas systems for saturating mutagenesis of non-c2023
Targeting BCL11A enhancer functional regions for fetal hemoglobin reinduction2023
Targeting BCL11A distal regulatory elements for fetal hemoglobin reinduction2023
Androgenetic haploid embryonic stem cell (AG-HAESC), and preparation method and 2022